- Efficacy and safety of ixekizumab in a randomized, double-blinded, pl…
Number of the records: 1  

Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis

  1. RYAN, Caitriona. Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled, phase 3b clinical trial in patients with moderate-to-severe genital psoriasis. In kongres slovenských a českých dermatovenerológov s medzinárodnou účasťou, s. 19. [S.l. : s.n., 2018].
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.